Services | ABNewswire

Computation Ltd. Promotes Computer Repair and Electronics Recycling in Toronto During Earth Week

For Earth Week (April 18–24), Computation Ltd. is urging Torontonians to prioritize tech sustainability. As an ISO-certified leader in computer repair and electronics recycling Toronto, the company helps extend device lifespans and diverts e-waste from landfills. From secure data destruction … Continue reading →

Carolina Spine & Health Advances Non-Surgical Chiropractic Treatment in Greenville for Chronic Back Pain Relief

At Carolina Spine & Health, a dedicated female chiropractor provides expert chiropractic treatment in Greenville]to a patient in a bright, modern clinic near a sunlit window. Carolina Spine & Health announces the expansion of specialized chiropractic treatment in Greenville, SC. … Continue reading →

Panhandle Real Estate Investments Now Buys Land Across Florida, with a Focus on the Florida Panhandle

Panhandle Real Estate Investments – Florida’s local cash land buyer serving the Panhandle and beyond. Panama City-based cash buyer Panhandle Real Estate Investments has launched a new land buying program, offering Florida landowners a fast, hassle-free way to sell vacant … Continue reading →

PoliceReport.info offers a streamlined path to Maryland traffic accident records

Plymouth, Massachusetts – PoliceReport.info has expanded its coverage to include the state of Maryland, offering residents and visitors a clear path to obtain official crash and police reports. With over five hundred thirty cities and towns and busy corridors near Baltimore … Continue reading →

ALK-Positive NSCLC Pipeline Gains Momentum as 6+ Pharma Companies Advance Next-Generation Therapies | DelveInsight

ALK-Positive NSCLC Pipeline ALK-positive Non-Small Cell Lung Cancer Companies include Nuvalent, Shouyao Holdings, Xuanzhu Biopharmaceutical, Fochon Pharmaceutical, and others. The treatment landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC) is rapidly evolving, driven by continuous research and innovation from … Continue reading →

Restrictive Cardiomyopathy Market Set for Notable Growth Through 2034, Driven by Advancing Therapies and Rising Disease Awareness | DelveInsight

Restrictive Cardiomyopathy Market Restrictive Cardiomyopathy companies include Array Biopharma, AstraZeneca, Sanofi, Hoffmann-La Roche, Merck & Co., Pfizer, Capricor Therapeutics, MyoKardia, Janssen, GSK, Teva Pharmaceuticals, Cipla, and Sun Pharmaceuticals, among others. DelveInsight’s latest report, “Restrictive Cardiomyopathy Market Insights, Epidemiology, and Market … Continue reading →

Diarrhea Clinical Trial Pipeline Expands as 25+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Diarrhea Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Diarrhea pipeline landscape. It covers the Diarrhea Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diarrhea Pipeline … Continue reading →

Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Shows Potential with Active Contributions from 70+ Key Companies | DelveInsight

DelveInsight’s, “Antisense Oligonucleotide Therapeutics Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 90+ pipeline drugs in the Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the Antisense Oligonucleotide Therapeutics pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

c-MET-NSCLC Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “C-MET Non-Small Cell Lung Cancer (C-MET+ NSCLC) Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the C-MET Non-Small Cell Lung Cancer pipeline landscape. It covers the C-MET+ NSCLC pipeline drug profiles, including … Continue reading →

EGFR + NSCLC Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline landscape. It covers the EGFR + NSCLC … Continue reading →

Thursday - March 26, 2026

Category Archives: Services